Stay updated on ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page
- Check3 days agoChange DetectedThe page now displays an added revision label 'Revision: v3.3.4', and the previous 'v3.3.3' label appears to be removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe Locations sections were updated to include multiple site locations (Aichi-ken, Chiba, Ehime, Fukuoka, Gifu, Gunma, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Ishikawa-ken, Iwate, Kanagawa, Miyagi, Nagano, Osaka, Saitama, Tokyo) and a new Revision: v3.3.3, with some previous location entries removed.SummaryDifference1%

- Check54 days agoChange DetectedMinor editorial updates to the Publications section clarify PubMed sourcing and update revision numbers (v3.3.2 in additions and v3.2.0 in deletions). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the banner about a lapse in government funding and the NIH Clinical Center operating status from the page.SummaryDifference0.2%

- Check75 days agoChange DetectedThere are no substantive changes to study details; the content such as eligibility criteria, primary outcomes, and locations appears unchanged, with only cosmetic formatting adjustments visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check104 days agoChange DetectedKey updates: version bump to v3.2.0 and the new government-operating-status notice; the previous v3.1.0 reference was removed. This indicates an update to status information and release version.”} }``` If the tool requires exact JSON, remove extra quotes? The structure shown: {SummaryDifference3%

Stay in the know with updates to ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.